Study on SARS-CoV-2 IN Republic of Guinea Bissau
This study investigates the diminishing levels of protection against SARS-CoV-2 infection among individuals who have fully recovered and BNT162b2 vaccinees who have not been infected. Researchers recently examined the features of natural and hybrid immunity to infections caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Their findings were reported...
Read moreFifth Covid-19 wave in 11 African countries: Guinea Bissau
11 nations from Africa occupy the fifth spot. An official from the Africa Centre for Disease Control said on Thursday that COVID-19 wave Coronavirus infections are on the increase in Africa but that they are getting less and less lethal. Ahmed Ogwell, the Deputy Head of the pan-African health organization,...
Read moreThe BCG vaccine’s mechanism of action is revealed: Republic of Guinea Bissau
The century-old Bacille Calmette-Guérin (BCG) vaccination against TB immunizes 100 million infants annually. Surprisingly, in places with prevalent TB, it protects neonates and babies against several bacterial and viral diseases unrelated to TB. There’s even proof it reduces COVID-19. Why the BCG vaccine? Why does it protect newborns so much?...
Read moreHealth measures in Guinea Bissau
In the first quarter of this year, WFP distributed 16 metric tons of specialized nutritious foods (Super Cereal Plus) to 48 nutritional recovery centers in the Oio, Bafatá, and Gabu regions to support a total of 915 targeted children as part of the prevention and moderate acute malnutrition (MAM)...
Read more